NYSE:ITGR - Get Free Report ) EVP John A. Harris sold 312 shares of the company's stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $113.00, for a total value of $35,256.00. Following the transaction, the executive vice president now directly owns 1,157 shares in the company, valued at $130,741. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link .
Get Integer alerts:
Sign Up
Integer Price Performance Shares of ITGR stock traded up $1.02 during trading hours on Thursday, hitting $114.16. The stock had a trading volume of 174,136 shares, compared to its average volume of 336,473. The stock has a market capitalization of $3.82 billion, a price-to-earnings ratio of 39.15, a PEG ratio of 1.65 and a beta of 1.12. The stock's 50-day moving average price is $114.66 and its two-hundred day moving average price is $101.98. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.32 and a quick ratio of 2.01. Integer Holdings Co. has a one year low of $69.40 and a one year high of $123.99.
Integer (NYSE:ITGR - Get Free Report ) last released its earnings results on Thursday, April 25th. The medical equipment provider reported $1.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.12 by $0.02. Integer had a net margin of 6.01% and a return on equity of 11.25%. The firm had revenue of $414.80 million during the quarter, compared to analyst estimates of $412.78 million. During the same quarter last year, the business earned $0.87 EPS. The business's revenue was up 9.5% on a year-over-year basis. Equities analysts forecast that Integer Holdings Co. will post 5.27 EPS for the current year.
Wall Street Analysts Forecast Growth Several research analysts have weighed in on the stock. CL King initiated coverage on shares of Integer in a research report on Thursday, March 14th. They issued a "buy" rating and a $137.00 price target on the stock. Bank of America raised shares of Integer from a "neutral" rating to a "buy" rating and lifted their price target for the company from $105.00 to $135.00 in a report on Monday, April 15th. KeyCorp raised their price objective on shares of Integer from $123.00 to $139.00 and gave the company an "overweight" rating in a research report on Tuesday, April 9th. Finally, Benchmark reaffirmed a "buy" rating and issued a $130.00 target price on shares of Integer in a report on Friday, April 26th. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to MarketBeat.com, Integer has a consensus rating of "Moderate Buy" and an average price target of $120.50.
View Our Latest Analysis on ITGR
Institutional Investors Weigh In On Integer Institutional investors and hedge funds have recently modified their holdings of the business. Fuller & Thaler Asset Management Inc. increased its stake in Integer by 497.0% in the third quarter. Fuller & Thaler Asset Management Inc. now owns 536,343 shares of the medical equipment provider's stock worth $42,065,000 after purchasing an additional 446,508 shares during the period. Public Employees Retirement Association of Colorado lifted its holdings in Integer by 3,260.1% during the 4th quarter. Public Employees Retirement Association of Colorado now owns 285,439 shares of the medical equipment provider's stock valued at $28,281,000 after buying an additional 276,944 shares in the last quarter. Norges Bank purchased a new stake in Integer in the 4th quarter valued at about $18,697,000. Victory Capital Management Inc. raised its holdings in Integer by 8.9% in the third quarter. Victory Capital Management Inc. now owns 1,632,549 shares of the medical equipment provider's stock worth $128,041,000 after purchasing an additional 133,898 shares in the last quarter. Finally, FMR LLC lifted its position in shares of Integer by 12.8% during the third quarter. FMR LLC now owns 863,938 shares of the medical equipment provider's stock valued at $67,759,000 after buying an additional 97,851 shares during the last quarter. 99.29% of the stock is owned by institutional investors.
About Integer (
Get Free Report )
Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Featured Stories This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Integer, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Integer wasn't on the list.
While Integer currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
